Product category:
Analytical, statistical and report generating software
News Release from: Bruker Daltonics | Subject: FlexImaging 2.0
Edited by the Laboratorytalk Editorial
Team on 25 January 2007
Maldi mass and class imaging in drug
discovery
At the 18th ASMS Sanibel Conference on Imaging Mass Spectrometry, Bruker Daltonics announced the release of FlexImaging 2.0 software for acquisition and evaluation of Maldi-Tof and Tof/Tof images
Maldi imaging of tissue samples with Bruker's novel flexImaging 2.0 allows colour-coded visualisation of the distribution of biomarkers or absorbed drugs and their major metabolites The company's Maldi imaging solutions provide a tool for the direct analysis of biomarker candidates or drug/metabolite distributions in tissue sections (for research use only)
This article was originally published on Laboratorytalk on 2 Jun 2006 at 8.00am (UK)
Related stories
Integrated statistical image analysis of tissues
Integrated software packages allow researchers to merge statistical analysis on Maldi-Tof profiling spectra with molecular images of tissue distributions of peptide and protein biomarkers
Revolutionary ultra-high resolution TOF mass spec
At ASMS 2008, Bruker Daltonics announced the Maxis, a revolutionary new electrospray ultra-high resolution tandem TOF (UHR-Qq-TOF) mass spectrometer
Revolutionary mass spectrometer at ASMS conference
Bruker Daltonics will host a Users Symposium on Sunday 1 June to introduce Maxis, a novel high-speed, ultra high resolution time-of-flight (UHR-tof) mass spectrometer to the marketplace
Integrating multivariate statistical classifications such as PCA or variance ranking, flexImaging 2.0 now provides Class Imaging as an extension to the established Mass Imaging.
Class imaging (patent pending) uniquely allows the classification of tissue types, such as mamma carcinoma, and determination of the class membership of comparable tissues/biopsies, eg, from other individuals or from animals used in drug development.
Michael Schubert, executive vice president of Bruker Daltonics, commented: "Statistical biomarker or drug/metabolite data obtained with the Flex series Maldi-Tof and Tof/Tof mass spectrometers can now be merged easily with molecular images for in-depth investigation of the spatial distribution of relevant marker candidates in tissues.
"We expect this breakthrough technology to further the diagnostics and pathology research, as well as the drug development applications of Maldi imaging".
At the Sanibel conference, Bruker Daltonics also is pre-viewing its novel matrix deposition device, ImagePrep, which is specifically tailored to the requirements of Maldi Imaging.
Very promising results from this innovative device (patents pending) will be presented.
The ImagePrep is scheduled for formal product launch later in 2007. Request a free brochure from Bruker Daltonics ...
• Bruker Daltonics: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
